The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans
Abstract
Scope: Trisomy for human chromosome 21 results in D own syndrome (DS), which is among the most complex genetic perturbations leading to intellectual disability. Accumulating data suggest that overexpression of the dual‐specificity tyrosine‐(Y)‐phosphorylation regulated kinase 1A (DYRK 1 A), is a critical pathogenic mechanisms in the intellectual deficit. Methods and results: Here we show that the green tea flavonol epigallocatechin‐gallate (EGCG), a DYRK 1 A inhibitor, rescues the cognitive deficits of both segmental trisomy 16 (T s65 D n) and transgenic mice overexpressing Dyrk1A in a trisomic or disomic genetic background, respectively. It also significantly reverses cognitive deficits in a pilot study in DS individuals with effects on memory recognition, working memory and quality of life. We used the mouse models to ensure that EGCG was able to reduce DYRK 1 A kinase activity in the hippocampus and found that it also induced significant changes in plasma homocysteine levels, which were correlated with Dyrk1A expression levels. Thus, we could use plasma homocysteine levels as an efficacy biomarker in our human study. Conclusion: We conclude that EGCG is a promising therapeutic tool for cognitive enhancement in DS, and its efficacy may depend of Dyrk1A inhibition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The specificities of protein kinase inhibitors: an update
BAIN, J., McLAUCHLAN, H., ELLIOTT, M., & COHEN, P. (2003) · Biochemical Journal · doi:10.1042/bj20021535 · Cited by 1,369 · cited 1×
“EGCG is a potent and selective inhibitor of DYRK1A activity [22].”
BackgroundA mouse model for Down syndrome exhibits learning and behaviour deficits
Reeves, R. H., Irving, N. G., Moran, T. H., Wohn, A., Kitt, C., Sisodia, S. S., Schmidt, C., Bronson, R. T., & Davisson, M. T. (1995) · Nature Genetics · doi:10.1038/ng1095-177 · Cited by 913
Meunier, M., Bachevalier, J., Mishkin, M., & Murray, E. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-12-05418.1993 · Cited by 901
Winters, B. D., Forwood, S. E., Cowell, R. A., Saksida, L. M., & Bussey, T. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1346-04.2004 · Cited by 586
Anti‐infective properties of epigallocatechin‐3‐gallate (EGCG), a component of green tea
Steinmann, J., Buer, J., Pietschmann, T., & Steinmann, E. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12009 · Cited by 559
Cognitive deficits and associated neurological complications in individuals with Down's syndrome
Lott, I. T., & Dierssen, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70112-5 · Cited by 484
Self-citationNutraceutical Antioxidants as Novel Neuroprotective Agents
Kelsey, N. A., Wilkins, H. M., & Linseman, D. A. (2010) · Molecules · doi:10.3390/molecules15117792 · Cited by 480
Bachevalier, J., & Mishkin, M. (1986) · Behavioural Brain Research · doi:10.1016/0166-4328(86)90225-1 · Cited by 445
Altafaj, X. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.18.1915 · Cited by 396
Effects of Green Tea and EGCG on Cardiovascular and Metabolic Health
Wolfram, S. (2007) · Journal of the American College of Nutrition · doi:10.1080/07315724.2007.10719626 · Cited by 370
Fotaki, V., Dierssen, M., Alcántara, S., Martínez, S., Martí, E., Casas, C., Visa, J., Soriano, E., Estivill, X., & Arbonés, M. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.18.6636-6647.2002 · Cited by 338
Self-citationDown syndrome: the brain in trisomic mode
Dierssen, M. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3314 · Cited by 274
Self-citationMégarbané, A., Ravel, A., Mircher, C., Sturtz, F., Grattau, Y., Rethoré, M.-O., Delabar, J.-M., & Mobley, W. C. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e3181b2e34c · Cited by 260
Self-citationCritical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome.
Rahmani, Z., Blouin, J. L., Creau-Goldberg, N., Watkins, P. C., Mattei, J. F., Poissonnier, M., Prieur, M., Chettouh, Z., Nicole, A., & Aurias, A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5958 · Cited by 258
A behavioral assessment of Ts65Dn mice: a putative Down syndrome model
Escorihuela, R. M., Fernández-Teruel, A., Vallina, I. F., Baamonde, C., Lumbreras, M. A., Dierssen, M., Tobeña, A., & Flórez, J. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12052-6 · Cited by 239
Self-citationGreen Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A
Guedj, F., Sébrié, C., Rivals, I., Ledru, A., Paly, E., Bizot, J. C., Smith, D., Rubin, E., Gillet, B., Arbones, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004606 · Cited by 216
Self-citationAmygdala and hippocampal volumes in children with Down syndrome: A high-resolution MRI study
Pinter, J. D., Brown, W. E., Eliez, S., Schmitt, J. E., Capone, G. T., & Reiss, A. L. (2001) · Neurology · doi:10.1212/wnl.56.7.972 · Cited by 197
Braudeau, J., Delatour, B., Duchon, A., Pereira, P. L., Dauphinot, L., de Chaumont, F., Olivo-Marin, J.-C., Dodd, R., Hérault, Y., & Potier, M.-C. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111405366 · Cited by 166
Self-citationAneuploidy: From a Physiological Mechanism of Variance to Down Syndrome
Dierssen, M., Hérault, Y., & Estivill, X. (2009) · Physiological Reviews · doi:10.1152/physrev.00032.2007 · Cited by 160
Self-citationLepagnol-Bestel, A.-M., Zvara, Á., Maussion, G., Quignon, F., Ngimbous, B., Ramoz, N., Imbeaud, S., Loe-Mie, Y., Benihoud, K., Agier, N., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp047 · Cited by 157
Self-citationSegregation of Areas Related to Visual Working Memory in the Prefrontal Cortex Revealed by rTMS
Mottaghy, F. M. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.4.369 · Cited by 157
Vicari, S., Bellucci, S., & Carlesimo, G. A. (2005) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162205000599 · Cited by 157
Distinct roles for medial temporal lobe structures in memory for objects and their locationsPreprint
Buffalo, E. A., Bellgowan, P. S. F., & Martin, A. D. (2006) · Learning & Memory · doi:10.1101/lm.251906 · Cited by 140
Measurement of homocyst(e)ine in the prediction of arteriosclerosis
Fortin, L.-J., & Genest, J. (1995) · Clinical Biochemistry · doi:10.1016/0009-9120(94)00073-5 · Cited by 126
Brock, J., & Jarrold, C. (2004) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2004.00352.x · Cited by 122
Redox Properties of Tea Polyphenols and Related Biological Activities
Sang, S., Hou, Z., Lambert, J. D., & Yang, C. S. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1704 · Cited by 120
Wang, Y., Li, M., Xu, X., Song, M., Tao, H., & Bai, Y. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200035 · Cited by 116
Scales, T. M. E., Lin, S., Kraus, M., Goold, R., & Gordon‐Weeks, P. R. (2009) · Journal of Cell Science · doi:10.1242/jcs.040162 · Cited by 113
de Lagrán, M. M., Benavides‐Piccione, R., Ballesteros‐Yáñez, I., Calvo, M., Morales, M., Fillat, C., DeFelipe, J., Ramakers, G. J. A., & Dierssen, M. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr362 · Cited by 112
Self-citationImpaired spatial working and reference memory in segmental trisomy (Ts65Dn) mice
Demas, G. E., Nelson, R. J., Krueger, B. K., & Yarowsky, P. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00116-2 · Cited by 101
Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/− mouse
Benavides‐Piccione, R., Dierssen, M., Ballesteros‐Yáñez, I., de Lagrán, M. M., Arbonés, M. L., Fotaki, V., DeFelipe, J., & Elston, G. N. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.02.004 · Cited by 98
Self-citationOrtiz-Abalia, J., Sahún, I., Altafaj, X., Andreu, N., Estivill, X., Dierssen, M., & Fillat, C. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.09.010 · Cited by 88
Self-citationFrenkel, S., & Bourdin, B. (2008) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2008.01139.x · Cited by 77
Altafaj, X., Martín, E. D., Ortiz-Abalia, J., Valderrama, A., Lao-Peregrín, C., Dierssen, M., & Fillat, C. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.11.017 · Cited by 75
Self-citationEngineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations
Toiber, D., Azkona, G., Ben‐Ari, S., Torán, N., Soreq, H., & Dierssen, M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.06.011 · Cited by 61
Self-citationPapadopoulos, C., Arató, K., Lilienthal, E., Zerweck, J., Schutkowski, M., Chatain, N., Müller-Newen, G., Becker, W., & de la Luna, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.157909 · Cited by 56
Noll, C., Planque, C., Ripoll, C., Guedj, F., Díez-Betriu, A., Ducros, V., Belin, N., Duchon, A., Paul, J., Badel, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007540 · Cited by 54
Self-citationTranscriptional Map of the 2.5-Mb CBR–ERG Region of Chromosome 21 Involved in Down Syndrome
Dahmane, N., Ait‐Ghezala, G., Gosset, P., Chamoun, Z., Dufresne-Zacharia, M.-C., Lopes, C., Rabatel, N., Maugenre, S., Chettouh, Z., Abramowski, V., et al. (1998) · Genomics · doi:10.1006/geno.1997.5146 · Cited by 45
Self-citationTurriziani, P., Oliveri, M., Salerno, S., Costanzo, F., Koch, G., Caltagirone, C., & Carlesimo, G. A. (2008) · Behavioural Neurology · doi:10.1155/2008/568057 · Cited by 37
Working memory in the aged Ts65Dn mouse, a model for Down syndrome
Whitney, K. N., & Wenger, G. R. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.03.042 · Cited by 11
Working memory in the Ts65Dn mouse, a model for Down syndrome
Dowdy‐Sanders, N. C., & Wenger, G. R. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.11.020 · Cited by 8
Cited by
The safety of green tea and green tea extract consumption in adults – Results of a systematic review
Hu, J., Webster, D., Cao, J., & Shao, A. (2018) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2018.03.019 · Cited by 405
Scientific opinion on the safety of green tea catechins
(ANS), E. P. O. F. A. A. N. S. A. T. F., Younes, M., Aggett, P., Aguilar, F., Crebelli, R., Dusemund, B., Filipič, M., Frutos, M. J., Galtier, P., Gott, D., et al. (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5239 · Cited by 317
Down syndrome and the complexity of genome dosage imbalance
Antonarakis, S. E. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.154 · Cited by 299
de la Torre, R., de Sola, S., Hernandez, G., Farré, M., Pujol, J., Rodriguez, J., Espadaler, J. M., Langohr, K., Cuenca-Royo, A., Principe, A., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30034-5 · Cited by 289
Self-citationBallard, C., Mobley, W., Hardy, J., Williams, G., & Corbett, A. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00063-6 · Cited by 264
Metadata
- Authors
- De la Torre, R., De Sola, S., Pons, M., Duchon, A., de Lagran, M. M., Farré, M., Fitó, M., Benejam, B., Langohr, K., Rodriguez, J., Pujadas, M., Bizot, J. C., Cuenca, A., Janel, N., Catuara, S., Covas, M. I., Blehaut, H., Herault, Y., Delabar, J. M., & Dierssen, M.
- Venue
- Molecular Nutrition & Food Research
- Publisher
- Wiley
- Published
- 2013-09-14
- Volume
- 58
- Issue
- 2
- Pages
- 278-288
- ISSN
- 1613-4125 (ISSN-L)
- 1613-4133
- OpenAlex
- W2051685982
- Cited by
- 286
- References
- 41
- FWCI
- 23.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.